Your Messages Inbox
Your Article Summary
See Latest ArticlesBiopure Receives Notices About Nasdaq Listing Compliance
BioPure, 08/04/09
Biopure Corporation announced that it has received several notices from The Nasdaq Stock Market. By letter dated March 24, 2009, Nasdaq advised that, as the company had not yet filed its Form 10–Q for the fiscal quarter ended January 2009, it was out of compliance with the Nasdaq Marketplace Rules. The company filed the report and received a letter dated March 2009, stating that the matter was closed.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09
Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09
New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09
Article Search
Sponsor